1. Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer
   Yong Joon Lee et al, 2018, Scientific Reports CrossRef
2. Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma
   Shuichi Aoki et al, 2022, Gut CrossRef
3. Evaluation of potential tumor markers that may predict neoadjuvant treatment efficiency in rectal cancer
   Fatma Demet Arslan et al, 2021, Turkish Journal of Biochemistry CrossRef
4. Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models
   Moying Li et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
5. Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7
   Aïssata Aimée Goïta et al, 2022, Cancers CrossRef
6. Expression of vascular endothelial growth factor as a predictor of complete response for preoperative chemoradiotherapy in rectal cancer
   Jesang Yu et al, 2019, Medicine CrossRef
7. SDF-1 expression after preoperative chemoradiotherapy is associated with prognosis in patients with advanced lower rectal cancer
   Shohei Okikawa et al, 2021, The Journal of Medical Investigation CrossRef
8. SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
   Ruo-Xi Wang et al, 2022, Frontiers in Immunology CrossRef
9. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review
   Chao Wang et al, 2023, Oncology Research and Treatment CrossRef
10. Predicting pathological response to chemoradiotherapy for rectal cancer: a systematic review
    Jesse Fischer et al, 2021, Expert Review of Anticancer Therapy CrossRef